All In Biotech

Free tool

FAERS Monitor: Lomotil

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 012462 or its brand name (Lomotil, Atropine Sulfate, Diphenoxylate Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

13,731

Serious

9,029

66% of reports

Hospitalization

5,264

Death reported

1,344

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea2,763
  • nausea1,634
  • fatigue1,495
  • drug ineffective1,136
  • vomiting926
  • weight decreased892
  • pain786
  • dehydration774
  • off label use756
  • abdominal pain749
  • asthenia725
  • headache683
  • dyspnoea680
  • decreased appetite654
  • malaise597

Reports by year received

View as table
YearReports
2004219
2005185
2006220
2007211
2008250
2009302
2010333
2011428
2012616
2013574
2014669
20151,093
20161,027
20171,083
20181,119
2019920
2020913
2021722
2022618
2023595
2024582
2025681
2026371

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,428 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dehydrationSignal7748.98.35,449
diarrhoeaSignal2,7636.66.413,426
abdominal painSignal7494.94.62,372
weight decreasedSignal8924.94.62,799
decreased appetiteSignal6544.34.01,681
nauseaSignal1,6343.23.02,510
vomitingSignal9263.02.81,276
astheniaSignal7253.02.8952
fatigueSignal1,4952.92.81,989
malaiseSignal5972.11.9343
pain7862.01.8380
dyspnoea6801.81.7267
headache6831.71.6188
off label use7561.31.262
drug ineffective1,1361.31.294

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.